These findings collectively indicated that the MedDiet’s potential to modulate cognitive health-related metabolites varied by APOE4 genotype, suggesting that this dietary pattern could be an effective strategy to delay dementia onset in APOE4 homozygotes, despite their higher risk profile. This evidence concerns the gene APOE and dementia.